CLDN18.2-Specific CAR T-Cell Therapy Prolongs PFS in Patients with Previously Treated Advanced Gastric or Gastro-oesophageal Junction Cancer By Ogkologos - August 14, 2025 615 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CT041-ST-01 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Tipifarnib Demonstrates Encouraging Efficacy in Patients with Recurrent and/or Metastatic HNSCC... April 21, 2021 Not Old Enough for Breast Cancer, She Demanded a Mammogram Anyway... September 16, 2020 EMA Recommends Granting a Marketing Authorisation for Vimseltinib September 5, 2025 New Blood Test Can Screen For Over 50 Cancers June 7, 2021 Load more HOT NEWS A Combination of Oral Mezigdomide Plus Dexamethasone Shows Promising Efficacy in... The team of over 60 scientists investigating the age-old mystery of... Easy Meals at Home 3 Steps to Making the Right Decisions for You During Cancer:...
